Get Started

RNA

NASD Atrium Therapeutics, Inc.
Nov 3, 2026 · 8:26 AM ET LAST TRADE Market Closed

$8.55 ↑ +0.00 (+0.00%) Trading Up from the previous close of $8.55

YTD change
-88.15%
vs 20-day SMA
+5.88%
vs 200-day SMA
-58.40%

Price ranges

Previous day
$8.19 $8.64
open $8.27 close $8.55
+$0.28 (+3.39%)
Today
$0.00 $0.00
$8.55
Past week
$7.88 $8.65
from $8.05 now $8.55
+$0.50 (+6.21%)
Past month
$7.49 $8.65
from $7.97 now $8.55
+$0.58 (+7.28%)
This year
$7.49 $73.06
from $72.13 now $8.55
-$63.58 (-88.15%)

Price & Performance

-4.32 (-33.57%) / 6M

$7.05$9.75$12.46$15.16May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 88.3% away from all-time highs of $73.06
  • RNA is down 88% since the beginning of the year
  • RNA is down 88% over the past 12 months
  • RNA is up 7% over the past 1 month
  • 22% of all RNA investors are betting against RNA

RNA reads neutral: price sits above one of the two key moving averages, the 12-month move is -87.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.18
Earnings momentum -45.5% Quarterly EPS growth
Quarterly change -45.5%

Valuation

P/E ratio -14.65
Enterprise value $-116272000.0
Beta 0.96

Balance sheet & scale

IncomeN/A
Revenue$35.8M
Cash$264.2M
Debt$1.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $190.5M

Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need. The company was founded on September 30, 2025 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $465.45 -0.12%
MRNA Moderna, Inc. $220.83 -0.40%
RVMD Revolution Medicines, Inc. $188.17 -1.64%
ROIV Roivant Sciences Ltd. $35.89 -2.76%
BNTX BioNTech SE Sponsored ADR $87.53 -0.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.